Applied Therapeutics stock (APLT) was down 75% early Friday on news the FDA had declined to approve its drug govorestat, ...

Nvidia's sales nearly doubled YoY, with profits growing even faster than sales. Find out why NVDA stock is a Buy.

I maintain a hold rating on Kohl’s Corp due to persistent poor demand. 3Q24 results showed an 8.5% revenue decline, with same ...

Teladoc Health, Inc. (NYSE:TDOC) stock is primed to move higher in 2025. That's a bold statement, right? After all, if we are ...

The major averages are higher on Friday, in a holiday shortened week, as Wall Street came off from the Thanksgiving break.

That debt rating alone tells anyone considering an investment that the level of debt is not an issue for this investment idea ...

BellRing Brands has consistently outperformed expectations, delivering strong earnings and robust growth, particularly in its ...

Lam Research is well-positioned for long-term growth due to its leadership in semiconductor technology and strategic focus on ...

Ford's EV business is a significant loss-maker, dragging down overall margins and earnings, with no improvement in sight. See ...

Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key ...

ASML Holding, leader in EUV lithography machines, presents a buying opportunity after a 40% correction, driven by strong ...

JQUA which fishes for high-quality, low-risk stocks from the Russell 1000, appears to be a much better offering than the most ...